Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,101-1,125 of 2,022
CompletedNCT02411695

Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia

This study exists to better understand the safety of a digital app or remote support tool and how manageable it feels in practice. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 13 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
CompletedNCT00001486

Genetic Study of Schizophrenia

This study exists to explore whether the medication Schizophrenia could improve care and understanding. Researchers are trying to understand whether the medication Schizophrenia can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
RecruitingNCT05778591

Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
RecruitingNCT01730781

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand what smoking support or smoking-related treatment can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT07545941

The Effects of an Online Family Psychoeducation Program on Expressed Emotion of Family Members and Medication Adherence of Patients With First-Episode Schizophrenia

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Thailand
Sponsor
Mahidol University
Condition
Schizophrenia
RecruitingNCT06969755

Biomarkers to Enhance Early Schizophrenia Treatment

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
Canada, United States
Sponsor
Northwell Health
Condition
Schizophrenia
RecruitingNCT06649552

French Validation of Schizophrenia Proneness Instrument- Child Youth

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 12 Years to 17 Years
Countries
France
Sponsor
Centre Psychothérapique de Nancy
Condition
Schizophrenia
Active Not RecruitingNCT05622201

A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Sweden
Sponsor
Region Örebro County
Condition
Schizophrenia
CompletedNCT07550387

A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia

This study exists to compare options and see whether the medication HS-10380 offers something meaningfully different. Researchers are trying to understand how people respond to the medication HS-10380 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Condition
Schizophrenia
WithdrawnNCT03729791

The Effect of tDCS on Schizophrenia With Negative Symptoms

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
South Korea
Sponsor
Seoul National University Hospital
Condition
Schizophrenia
RecruitingNCT01409109

Database Registry for Neural Network Biomarkers in Psychosis

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia
TerminatedNCT05724810

Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand what smoking support or smoking-related treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Stony Brook University
Condition
Schizophrenia
CompletedNCT05204407

Luteolin for the Treatment of People With Schizophrenia

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
SuspendedNCT05567848

Accelerated TMS in Psychosis

This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Condition
Schizophrenia
RecruitingNCT06947941

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Australia, Canada, Japan, United Kingdom, United States
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
RecruitingNCT05796401

Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 30 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Schizophrenia
CompletedNCT00004571

Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 120 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
CompletedNCT07524868

Effect of Cognitive Behavioral Therapy on Auditory Hallucinations and NLR in Schizophrenia Patients

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 20 Years to 50 Years
Countries
Indonesia
Sponsor
Hasanuddin University
Condition
Schizophrenia
RecruitingNCT05973110

Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Canada
Sponsor
The Royal Ottawa Mental Health Centre
Condition
Schizophrenia
CompletedNCT05473741

Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

This study exists to see whether questionnaires and follow-up reports can make care clearer and more responsive. Researchers are trying to understand whether questionnaires and follow-up reports can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT04478838

"Extended" (Alternate Day) Antipsychotic Dosing

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia